SiDaLuk
SiDaLuk is developing a new diagnostic assay for automated diagnosis of prostate cancer. Prostate cancer is the most common cancer among American men and second leading cause of cancer-related death. About 23 million men are screen for prostate cancer ann
prostate cancer, cancer diagnostics, prostate research, prostate specific antigen, PSA, SiDaLuk, Sinisa Vukelic, cander treatment
Is this your site? Certify your site and update informations
